Ravulizumab for Myasthenia Gravis User Reviews
Brand names: Ultomiris
Ravulizumab has an average rating of 10.0 out of 10 from a total of 4 reviews for the treatment of Myasthenia Gravis. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
- Marge
- Taken for less than 1 month
- January 22, 2023
Ultomiris (ravulizumab) "Quick and easy infusion. No side effects noted. Felt great the day after. Benefits: Less time in the infusion chair, no pre mediations needed, no allergic reactions afterwards."
- Emscu...
- Taken for 1 to 6 months
- April 30, 2023
Ultomiris (ravulizumab) "Quick infusion. Small reaction but disappeared once nurse slowed it down. Felt better within a week."
- COdan...
- Taken for 6 months to 1 year
- July 30, 2023
Ultomiris (ravulizumab) "I have been successful with the use of Ultomiris for the past 8 months. My MG symptoms are minimal or alleviated. Receiving treatment every eight weeks has given me more freedom to travel and work."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Myasthenia Gravis
Care guides
Symptoms and treatments
More about ravulizumab
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Ultomiris (ravulizumab) "On Ultomiris about 14 months now, no real side effects. This drug is great for my M.G. and has greatly improved all of my symptoms and also gave me a better life."